Nila | $2,400,000 | (Oct 17, 2025)
Upciti | $20,000,000 | (Oct 17, 2025)
MGT Insurance | $21,600,000 | (Oct 17, 2025)
Certified by Founder
Lodge
Indapta Therapeutics
start up
United States
- Seattle & Houston
- 18/12/2024
- Unknown
- $22,500,000
Indapta's allogeneic g-NK cells have highly potent ADCC activity, making them the ideal therapy to combine with IgG1 monoclonal antibodies, ADCs, or innate immune cell engager molecules.
- Industry Biotechnology
- Website https://indapta.com/
- LinkedIn https://www.linkedin.com/company/indapta-therapuetics/
Sonic Fire Tech | $3,500,000 | (Oct 17, 2025)
Strella | $14,000,000 | (Oct 17, 2025)
Temple Digital Group | $5,000,000 | (Oct 17, 2025)
ATDev | $3,000,000 | (Oct 17, 2025)
Jack and Jill | $20,000,000 | (Oct 17, 2025)
Brook Health | $28,000,000 | (Oct 17, 2025)
Vega Health | $4,000,000 | (Oct 17, 2025)
ExaCare AI | $30,000,000 | (Oct 17, 2025)
Daylight(US) | $75,000,000 | (Oct 17, 2025)